Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients

NCT00660907 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1217

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: dapagliflozin
DRUG: glipizide
DRUG: metformin hydrochloride

Sponsor

AstraZeneca

Collaborators

[object Object]